Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.

@article{McGill2004Circulating1L,
  title={Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.},
  author={Janet B. McGill and Thomas G. Cole and William L Nowatzke and Shannon Houghton and Erika B Ammirati and Theresa C Gautille and Mark J. Sarno},
  journal={Diabetes care},
  year={2004},
  volume={27 8},
  pages={1859-65}
}
OBJECTIVE 1,5-Anhydroglucitol (1,5AG) is a major circulating polyol arising primarily from ingestion and excreted competitively with glucose. Japanese studies have demonstrated reduced concentrations of 1,5AG in serum in hyperglycemic patients in comparison with euglycemic subjects and a gradual normalization of 1,5AG values for patients responding to antihyperglycemic therapies. In this first U.S. study, we assessed the ability of 1,5AG measurements to monitor glycemic control in a cohort of… CONTINUE READING
42 Citations
20 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 42 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Melli

  • T Yamanouchi, N Ogata, +4 authors H Miyashita
  • Diabetes Care
  • 2002

Intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes ( UKPDS 34 )

  • CM Peterson, L Jovanovic
  • Lancet
  • 1998

Similar Papers

Loading similar papers…